We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Citing Benefit Amid Epidemic, FDA Advisors Say Yes to Opioid Dependence Implant
Citing Benefit Amid Epidemic, FDA Advisors Say Yes to Opioid Dependence Implant
Titan Pharmaceuticals won positive news from an FDA advisory committee Jan. 12, with panelists voting in favor of approving its implant to treat opioid addictions.